|Mr. Peter McFadden||Interim Pres, CEO & CFO||N/A||N/A||N/A|
|Mr. Blair C. Lowther||Corp. Sec. & Independent Director||N/A||N/A||N/A|
|Ms. Barbara J. Joe||Controller||N/A||N/A||N/A|
Veritas Pharma Inc., through its subsidiary, Cannevert Therapeutics Ltd. operates as a pharmaceutical and IP development company. It develops proprietary cannabis strains for chronic and acute pains, nausea and vomiting, and post-traumatic stress disorders. The company was formerly known as Seashore Organic Medicine Inc. and changed its name to Veritas Pharma Inc. in December 2015. Veritas Pharma Inc. was incorporated in 2014 and is headquartered in Vancouver, Canada.
Veritas Pharma Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.